Transient Ischaemic Attack is a transient episode of neurological dysfunction caused by focal brain, spinal-cord or retinal ischaemia without the established infarction that defines tissue-injury-based Stroke. Symptoms can resemble those of an ischaemic stroke, including sudden weakness, speech disturbance, visual loss, numbness or coordination problems, but they resolve because blood flow is restored before permanent tissue injury develops or because the affected tissue remains viable. The historical concept relied heavily on symptom duration, but modern definitions emphasise tissue injury rather than an arbitrary time limit. A Transient Ischaemic Attack is therefore a clinical warning event rather than a harmless mini-stroke.
The mechanisms responsible for Transient Ischaemic Attack overlap with those responsible for ischaemic Stroke. A temporary embolus can obstruct a cerebral artery and then dissolve or move onward, while unstable atherosclerotic plaque can generate small emboli. Severe narrowing of a major artery can produce transient low-flow episodes, particularly under circumstances that reduce cerebral perfusion. Cardiac conditions such as atrial fibrillation can provide a source of embolic material. Retinal ischaemia can produce transient monocular visual loss, sometimes described clinically as amaurosis fugax. The exact mechanism matters because secondary prevention should target the source of the vascular event.
Symptoms typically begin suddenly and reflect the function of the affected vascular territory. A person may experience unilateral weakness, facial asymmetry, difficulty speaking, inability to understand language, sudden monocular blindness, loss of coordination or sensory disturbance. Some symptoms can be difficult to distinguish from migraine, seizure, low blood glucose or other neurological disorders. The fact that symptoms disappear does not establish that the event was benign or that urgent assessment is unnecessary. A transient episode can signal unstable vascular disease or an embolic source that remains capable of causing a completed Stroke.
Evaluation generally involves urgent clinical assessment and investigation of possible vascular and cardiac causes. Brain imaging may identify an infarction that changes the classification from tissue-negative Transient Ischaemic Attack to ischaemic Stroke, while vascular imaging can assess carotid and intracranial arteries. Electrocardiography and longer cardiac monitoring may detect atrial fibrillation or other arrhythmias. Blood tests can evaluate relevant vascular risk factors and identify alternative explanations in appropriate circumstances. The diagnostic process is therefore broader than simply asking how long symptoms lasted.
Management is primarily directed at preventing subsequent vascular events. Depending on the mechanism, treatment can include antiplatelet therapy, anticoagulation for appropriate cardioembolic sources, lipid-lowering treatment, blood-pressure management, diabetes management and smoking cessation. Some people with symptomatic significant carotid artery narrowing may be considered for carotid intervention after specialist assessment. Short courses of dual antiplatelet therapy may be used in selected high-risk non-cardioembolic presentations, but the choice and duration require clinical assessment because antithrombotic treatment increases bleeding risk.
The risk following Transient Ischaemic Attack is not uniform. It depends on age, clinical features, vascular territory, underlying mechanism, imaging findings and other risk factors. This has led to structured clinical assessment tools and rapid-access TIA services in many healthcare systems. Such tools can assist triage but should not be used as substitutes for clinical evaluation or as reassurance that a low score makes urgent assessment unnecessary. Early specialist assessment can identify treatable causes such as atrial fibrillation or severe carotid disease and initiate prevention before a disabling Stroke occurs.
Transient Ischaemic Attack is closely related to Stroke but should not be treated as a minor version of it. The same initial symptoms can represent either condition, and the distinction may depend on imaging and evidence of tissue injury. Symptoms lasting only a few minutes can still represent a serious vascular warning. Conversely, not every transient neurological symptom is a Transient Ischaemic Attack because migraine aura, seizure, hypoglycaemia and other disorders can mimic it. Accurate diagnosis requires consideration of symptom pattern, vascular anatomy, risk factors and investigations rather than duration alone.
A major misconception is that once symptoms have completely resolved, the emergency has passed. Temporary resolution does not remove the possibility of an underlying unstable vascular or cardiac source. Sudden facial weakness, limb weakness, speech difficulty, visual loss or other focal neurological symptoms should receive urgent medical attention even when they disappear before assessment. Another misconception is that Transient Ischaemic Attack can be prevented solely through lifestyle changes; lifestyle modification is important, but medication or procedures may be necessary when specific causes are identified. Its significance lies primarily in the information it provides about future cerebrovascular risk and the opportunity for preventive intervention.
